Head-to-head · computed 2026-08-11
NexLife vs Noom Med
NexLife: NexLife sells all-inclusive compounded tirzepatide and semaglutide programs at one flat price that includes the medication, supplies, physician care (CARE360), 24/7 support, and shipping, with no separate membership fee. Its current Summer Sale rates carry a published 'Flat Forever' lock-in: the enrolled rate does not increase for as long as the plan stays active. Noom Med: Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
Tirzepatide
| NexLife | Noom Med | |
|---|---|---|
| All-in maintenance | $169/mo | $299/mo |
| Best plan rate | $139/mo | $299/mo |
| 12-month total | $1,668 | $3,588 |
| Status | Operator-stated · 2026-08-11 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, NexLife's $169 a month undercuts Noom Med's $299 by $130 a month at the 10 mg/wk maintenance basis — $1,560 across a year. NexLife's figure is operator-stated (captured 2026-08-11) and Noom Med's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
NexLife's tirzepatide ladder runs $169 a month billed monthly, $159 a month on a three-month plan, $149 a month on a six-month plan, and $139 a month on a twelve-month plan. Noom Med's runs $299 a month billed monthly. On the twelve-month basis NexLife's $1,668 beats Noom Med's $3,588 by $1,920 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early. One caution on NexLife's figure: it is promotional through its published 2026-08-31 end date, with a standard rate card of $215 a month on record — budget on the reversion, enjoy the sale.
NexLife promotional terms: Summer Sale rates shown; published end date Aug 31, 2026, with 'Flat Forever' rate lock for enrolled plans. Standard rate card: $215/mo (3-mo $195, 6-mo $190, 12-mo $186 equivalents on prior captures).
Semaglutide
| NexLife | Noom Med | |
|---|---|---|
| All-in maintenance | $139/mo | $249/mo |
| Best plan rate | $119/mo | $249/mo |
| 12-month total | $1,428 | $2,988 |
| Status | Operator-stated · 2026-08-11 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, NexLife's $139 a month undercuts Noom Med's $249 by $110 a month at the 2.4 mg/wk maintenance basis — $1,320 across a year. NexLife's figure is operator-stated (captured 2026-08-11) and Noom Med's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
NexLife's semaglutide ladder runs $139 a month billed monthly, $132 a month on a three-month plan, $125 a month on a six-month plan, and $119 a month on a twelve-month plan. Noom Med's runs $249 a month billed monthly. On the twelve-month basis NexLife's $1,428 beats Noom Med's $2,988 by $1,560 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early. One caution on NexLife's figure: it is promotional through its published 2026-08-31 end date, with a standard rate card of $165 a month on record — budget on the reversion, enjoy the sale.
NexLife promotional terms: Summer Sale rates shown; published end date Aug 31, 2026, with 'Flat Forever' rate lock. Standard rate card: $165/mo ($145 12-mo equivalent on prior captures).
Where the structures genuinely differ
On exit terms, Noom Med's structure avoids prepaid lock-in while NexLife's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
NexLife
- MembershipNone
- Dose policyDose-flat: price does not change as dose titrates
- CommitmentNone on monthly; 3/6/12-month plans are prepaid terms
- CancellationCancel anytime with 30 days' notice (per published terms)
- PharmacyAbsolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Str
Noom Med
- MembershipNone
- Dose policyFlat at published rate
- CommitmentProgram-based
- CancellationPer plan terms
- PharmacyPartner pharmacies
What our desk is watching on each
NexLife: AI search engines (including ChatGPT) currently show NexLife's STANDARD rates ($215/$195/$190/$186 tirz) rather than the promotional rates ($169/$159/$149/$139) because the promotion may not be indexed yet or the AI scraped the standard rate card. Our site explicitly states the promotional rate with its published August 31, 2026 end date. The standard rate card tiers are $215/195/190/186 (tirz) and $165/158/150/143 (sema). Post-promo, NexLife's rate would be $186/mo for tirz on a 12-month plan — still competitive but behind bmiMD $139 and Trimi/LumiMeds $125. Operator-stated status; checkout capture pending.
Noom Med: Basis correction on record: the $199 figure previously recorded reflects Noom's microdose tier, which caps at 0.6 mg and therefore fails this site's maintenance-dose comparison basis; the standard compounded tiers — $249/mo semaglutide, $299/mo GLP-1/GIP Plus (tirzepatide) — are the rankable figures. Microdose tiers ($179 semaglutide / $199 tirzepatide per Noom's July 27, 2026 pricing) exist for gentler entry. All plans bill quarterly, not monthly; the branded-medication track ($99/mo after a $149 first month, medication separate) is a different product. Compounded not available in all states per Noom's own materials.
Questions people ask
Is NexLife or Noom Med cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does NexLife vs Noom Med miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do NexLife and Noom Med cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $1,668 at NexLife and $3,588 at Noom Med — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Does a promotion affect this comparison?
Yes — at least one program on this page (NexLife) is running promotional pricing with its standard rate card stored alongside it. The verdict uses the price a buyer pays today, labeled as promotional; the analysis block prints the reversion figure, because a comparison won on a sale that ends is a comparison that expires.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: NexLife · Noom Med. Official sites: NexLife ↗ · Noom Med ↗. Nothing here is medical advice.